Karyopharm Therapeutics Inc. Quarterly Return On Equity in % from Q4 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Karyopharm Therapeutics Inc. quarterly/annual Return On Equity history and growth rate from Q4 2014 to Q3 2024.
  • Karyopharm Therapeutics Inc. Return On Equity for the quarter ending September 30, 2024 was 58.6 %, a 75.5% decline year-over-year.
  • Karyopharm Therapeutics Inc. annual Return On Equity for 2023 was 162 %, a 12.6% decline from 2022.
  • Karyopharm Therapeutics Inc. annual Return On Equity for 2022 was 186 %, a 22.8% increase from 2021.
  • Karyopharm Therapeutics Inc. annual Return On Equity for 2021 was 151 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 58.6 -181 -75.5% Jul 1, 2024 Sep 30, 2024
Q2 2024 66.9 -140 -67.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 123 -75.7 -38.1% Jan 1, 2024 Mar 31, 2024
Q4 2023 162 -23.4 -12.6% Oct 1, 2023 Dec 31, 2023
Q3 2023 239 +155 +185% Jul 1, 2023 Sep 30, 2023
Q2 2023 207 +105 +103% Apr 1, 2023 Jun 30, 2023
Q1 2023 198 +82.2 +70.7% Jan 1, 2023 Mar 31, 2023
Q4 2022 186 +34.4 +22.8% Oct 1, 2022 Dec 31, 2022
Q3 2022 84 -332 -79.8% Jul 1, 2022 Sep 30, 2022
Q2 2022 102 +7.31K Apr 1, 2022 Jun 30, 2022
Q1 2022 116 +474 Jan 1, 2022 Mar 31, 2022
Q4 2021 151 +334 Oct 1, 2021 Dec 31, 2021
Q3 2021 416 +604 Jul 1, 2021 Sep 30, 2021
Q2 2021 -7.2K -7.02K -3757% Apr 1, 2021 Jun 30, 2021
Q1 2021 -358 -150 -71.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -182 +72.3 +28.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -188 -0.42 -0.22% Jul 1, 2020 Sep 30, 2020
Q2 2020 -187 -32 -20.7% Apr 1, 2020 Jun 30, 2020
Q1 2020 -208 -88.4 -73.9% Jan 1, 2020 Mar 31, 2020
Q4 2019 -255 -147 -137% Oct 1, 2019 Dec 31, 2019
Q3 2019 -187 -82.8 -79.2% Jul 1, 2019 Sep 30, 2019
Q2 2019 -155 -56.9 -58.1% Apr 1, 2019 Jun 30, 2019
Q1 2019 -120 -16.4 -15.9% Jan 1, 2019 Mar 31, 2019
Q4 2018 -108 -18 -20.1% Oct 1, 2018 Dec 31, 2018
Q3 2018 -105 -27.7 -36% Jul 1, 2018 Sep 30, 2018
Q2 2018 -97.9 -27.4 -39% Apr 1, 2018 Jun 30, 2018
Q1 2018 -103 -30.8 -42.6% Jan 1, 2018 Mar 31, 2018
Q4 2017 -89.6 -23.2 -34.9% Oct 1, 2017 Dec 31, 2017
Q3 2017 -76.8 -12.6 -19.7% Jul 1, 2017 Sep 30, 2017
Q2 2017 -70.4 -8.18 -13.1% Apr 1, 2017 Jun 30, 2017
Q1 2017 -72.4 -15.9 -28.1% Jan 1, 2017 Mar 31, 2017
Q4 2016 -66.4 -16.2 -32.4% Oct 1, 2016 Dec 31, 2016
Q3 2016 -64.2 -15.8 -32.5% Jul 1, 2016 Sep 30, 2016
Q2 2016 -62.2 -18.6 -42.7% Apr 1, 2016 Jun 30, 2016
Q1 2016 -56.5 -14.6 -35% Jan 1, 2016 Mar 31, 2016
Q4 2015 -50.2 -7.52 -17.6% Oct 1, 2015 Dec 31, 2015
Q3 2015 -48.4 Jul 1, 2015 Sep 30, 2015
Q2 2015 -43.6 Apr 1, 2015 Jun 30, 2015
Q1 2015 -41.9 Jan 1, 2015 Mar 31, 2015
Q4 2014 -42.7 Oct 1, 2014 Dec 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.